Stockscreener 앱 받기
1.05
2.78%
-0.03
시간 외 거래:
1.04
-0.01
-0.95%
Elutia Inc 주식(ELUT)의 최신 뉴스
Elutia Inc. (NASDAQ:ELUT) Q4 2025 earnings call transcript - MSN
Elutia (ELUT) Q4 2025 Earnings Call Transcript - AOL.com
Forecast Cut: Is Elutia Inc subject to activist investor interest2026 Earnings Surprises & Low Risk High Reward Ideas - baoquankhu1.vn
Aug Technicals: Is Elutia Inc subject to activist investor interest2026 Price Momentum & Weekly Momentum Stock Picks - baoquankhu1.vn
Elutia to Present at Sidoti's Small-Cap Virtual Investor Conference March 18-19 - Bitget
Elutia details tech to address infections in breast reconstruction - Stock Titan
Elutia Warns of Ongoing Nasdaq Delisting Risk Despite Recent Compliance Win - TipRanks
Elutia (ELUT) Grants Stock Options to New Hires - GuruFocus
Elutia announces grants of inducement awards - TipRanks
Exit Recap: Is Elutia Inc subject to activist investor interest2026 Market Mood & Detailed Earnings Play Strategies - baoquankhu1.vn
Elutia 2025 10-K: Revenue $12.3M, EPS (cont. ops) $(15.871)M - TradingView
Elutia (NASDAQ: ELUT) pivots to drug‑eluting biomatrix after asset divestitures - Stock Titan
Achieving Micron-Level Tolerances: CAD Optimization for Sub-10µm 3D Printing - AOL.com
Elutia Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) - Bitget
Elutia markets another product for sale as it pivots to breast reconstruction infection prevention - The Business Journals
Elutia Announces Grants of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - 富途牛牛
[Form 4] ELUTIA INC. Insider Trading Activity - Stock Titan
Elutia (ELUT) CEO receives stock from RSU vesting while shares withheld for taxes - Stock Titan
Elutia Q4 2025 slides: $88M sale funds pivot to breast reconstruction - Investing.com Australia
Elutia Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:ELUT) 2026-03-12 - Seeking Alpha
Elutia Reports Strong 2025 Financial Results, Advances NXT-41x for Breast Cancer Surgery, and Closes $88M BioEnvelope Sale to Boston Scientific - Minichart
Elutia Inc (ELUT) Q4 2025 Earnings Call Highlights: Revenue Growth and Strategic Moves Amid ... By GuruFocus - Investing.com Canada
Elutia Inc (ELUT) Q4 2025 Earnings Call Highlights: Revenue Grow - GuruFocus
Elutia outlines launch timeline for NXT-41x in $1.5B breast reconstruction market while strengthening leadership team - MSN
Elutia Q4 2025 slides: $88M sale funds pivot to breast reconstruction By Investing.com - Investing.com South Africa
Elutia Inc. (ELUT) Q4 2025 Earnings Call Transcript Summary - 富途牛牛
Elutia Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Elutia Reports Fourth Quarter and Full Year 2025 Financial Results; Initiates NXT-41 Regulatory Process - Bitget
Earnings call transcript: Elutia Q4 2025 beats forecasts, stock steady - Investing.com Australia
Earnings call transcript: Elutia Q4 2025 beats forecasts, stock steady By Investing.com - Investing.com India
Elutia Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Elutia earnings beat by $1.60, revenue topped estimates - Investing.com Canada
Elutia reports $3.3M Q4 revenue, $70.8M net income on BioEnvelope sale; $44.4M year-end cash - TradingView
ELUTIA ($ELUT) Releases Q4 2025 Earnings, Stock Rises - Quiver Quantitative
Elutia Q4 revenue rises on higher cardiovascular product sales - TradingView
ELUT: Q4 2025 revenue up 16% year-over-year; focus shifts to NXT-41x for breast reconstruction - TradingView
Elutia (NASDAQ: ELUT) posts 2025 profit as BioEnvelope sale cuts debt and funds NXT-41 - Stock Titan
ELUT: Q4 net income soared to $70.8M on BioEnvelope sale, with NXT-41x FDA process underway - TradingView
Elutia Inc. Adopts 2026 Inducement Award Plan and Files Form 8-K Disclosure - Minichart
Exploring Elutia's Earnings Expectations - Benzinga
Elutia Inc (ELUT) Q4 2025: Everything You Need To Know Ahead Of Earnings - GuruFocus
Elutia Adopts 2026 Inducement Equity Award Plan - TipRanks
Elutia (NASDAQ: ELUT) sets 2026 inducement plan for 2,000,000 share awards - Stock Titan
Elutia Inc expected to post a loss of 14 cents a shareEarnings Preview - TradingView
Elutia Regains Full Nasdaq Compliance, Strengthening Listing Status - The Globe and Mail
Elutia (ELUT) Expected to Announce Earnings on Wednesday - MarketBeat
Elutia regains compliance with Nasdaq listing requirements - Investing.com Australia
Elutia regains compliance with Nasdaq listing requirements By Investing.com - Investing.com Canada
Elutia regains Nasdaq compliance after meeting minimum bid price and MVLS - TradingView
0.85%
1.86%
자본화:
|
볼륨(24시간):